Guidelines for Diagnosing and Managing PCOS
Use the Rotterdam criteria for diagnosis in adults: presence of any two of the following—hyperandrogenism (clinical or biochemical), ovulatory dysfunction, or polycystic ovaries—after excluding other androgen-excess disorders. 1, 2, 3
Diagnostic Criteria
Adults
Key refinement: AMH can now substitute for pelvic ultrasound in adults only, simplifying diagnosis and avoiding invasive imaging in some cases 2, 3
Adolescents
Diagnosis requires BOTH: 5
- Irregular menstrual cycles (defined by time postmenarche)
- Clinical or biochemical hyperandrogenism
Critical caveat: Do NOT use polycystic ovarian morphology on ultrasound or AMH levels for diagnosis in adolescents—these are normal developmental findings in this age group 5
Adolescents with only one feature are considered "at risk" and require symptom management plus ongoing monitoring 5
Exclusion Testing
- Rule out other causes of androgen excess: congenital adrenal hyperplasia, Cushing syndrome, androgen-secreting tumors, thyroid dysfunction, and hyperprolactinemia 4, 6
First-Line Management: Lifestyle Intervention
Initiate multicomponent lifestyle programs combining diet, exercise, and behavioral strategies for ALL women with PCOS regardless of weight, before or concurrent with any medication. 1
Exercise Prescription
- Weight maintenance: ≥150 minutes/week moderate-intensity OR ≥75 minutes/week vigorous activity, plus resistance training twice weekly 1
- Weight loss: ≥300 minutes/week moderate-intensity OR ≥150 minutes/week vigorous activity 1
- Target heart rate during aerobic sessions: 70–90% of age-predicted maximum (220 minus age) 1
Dietary Approach
- Emphasize low-glycemic-index foods, high fiber, omega-3 fatty acids, Mediterranean-style patterns, and anti-inflammatory foods—no single diet is superior 1, 7
- Reduce sugar-sweetened beverages and fruit juices 1
- Focus on portion-size control 1
Weight Management Rationale
- Women with PCOS gain weight faster than unaffected peers, with acceleration beginning in adolescence 1
- Even 5–10% weight loss improves reproductive function, metabolic parameters, and psychological wellbeing 1
- Obesity worsens all PCOS manifestations including insulin resistance, hyperandrogenism, and psychological comorbidities 1
- Monitor body weight and waist circumference regularly 1
Pharmacologic Management
For Menstrual Irregularity and Hyperandrogenism (Non-Fertility Goals)
Combined oral contraceptive pills (COCPs) are first-line pharmacologic therapy for regulating menstrual cycles and treating hirsutism/acne in women not seeking pregnancy. 1, 4
- COCPs provide endometrial protection against hyperplasia/cancer risk from chronic anovulation 1
- In adolescents, use low-dose preparations 5
For Metabolic Features
- Metformin improves metabolic/glycemic abnormalities and menstrual irregularities 6, 5
- Metformin has limited or no benefit for hirsutism, acne, or infertility 6
- Consider metformin in adolescents for metabolic features and cycle regulation 5
For Infertility
- Clomiphene remains first-line therapy for ovulation induction 6
- The 2023 guideline emphasizes cheaper and safer fertility management approaches 3
Medications with Unfavorable Risk-Benefit
Comprehensive Screening and Long-Term Management
Psychological Health
Systematically screen all women with PCOS for depression, anxiety, eating disorders, body-image concerns, and low self-esteem. 1
- Address weight stigma sensitively during clinical encounters 1
- Mental health disorders are highly prevalent and may be linked to gut dysbiosis 8
Metabolic and Cardiovascular Screening
- Screen for risk factors for diabetes, cardiovascular disease, and metabolic syndrome 3, 4
- PCOS is now recognized as a cardiovascular disease risk-enhancing factor with elevated risk of myocardial infarction and stroke even during reproductive years 8
- Evaluate for obstructive sleep apnea 3
Endometrial Protection
Pregnancy Considerations
- Women with PCOS have high risk of adverse pregnancy outcomes requiring appropriate counseling and monitoring 3
Special Populations
Postmenopausal Women
- No consistent PCOS phenotype exists in postmenopausal women, making diagnosis problematic 6
- Focus on managing established metabolic and cardiovascular comorbidities 3
Transition Planning for Adolescents
- Establish lifelong health planning including healthy lifestyles, metabolic screening, and transition to adult care 5
- Use shared decision-making throughout management 5
Common Pitfalls to Avoid
- Do not use ultrasound or AMH for diagnosis in adolescents—these lead to overdiagnosis 5
- Do not delay lifestyle intervention while initiating medications—they should be concurrent 1
- Do not overlook psychological screening—depression and anxiety are as important as metabolic features 1, 3
- Do not minimize the importance of weight stigma—explain health risks while avoiding stigmatizing language 1, 5